Dartmouth-Hitchcock Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Dartmouth-Hitchcock Medical Center sits in the top decile of US sponsors by registered trial count (#85 of 15,742 sponsors by registered trial count).

427 total trials 52 currently recruiting 300 completed early-phase tilt top decile by trial count

Dartmouth-Hitchcock Medical Center: 427 sponsored US clinical trials, 52 recruiting.

Dartmouth-Hitchcock Medical Center sponsors 427 registered US clinical trials on ClinicalTrials.gov, 52 of them currently recruiting, and 300 completed. 25 of these trials are in Phase 3-4 (later-stage) and 84 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 12 trials.

Top-decile sponsor footprint

Dartmouth-Hitchcock Medical Center ranks in the top decile of sponsors by registered trial count (#85 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 53/100

300 of 352 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

427 total, page 3 of 9

COMPLETED Phase 1

The Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune Antibody Mediated Hemolytic Anemia

NCT05004259
COMPLETED NA

CONFIDENT: Supporting Long-term Care Workers During COVID-19

NCT05168800
COMPLETED NA

Subscapularis Indocyanine Green Perfusion Pilot Study

NCT05179941
TERMINATED NA

Acupuncture to Enhance for Pulmonary Rehab

NCT04947800
COMPLETED Phase 1

Nebulizer Delivery of Intranasal Scopolamine

NCT04999449
COMPLETED NA

A Culinary-Based Intensive Lifestyle Program for Patients With Obesity

NCT04624620
COMPLETED NA

The Effect of a Non-Operating Room Anesthesia (NORA) Safety Video on Clinician Anxiety and Perceived Self-Efficacy

NCT05220943
TERMINATED NA

Stoma Closure and Reinforcement Trial ll

NCT04916067
COMPLETED Early Phase 1

Utility of ICG in Benign Bone Tumors

NCT05075889
COMPLETED NA

CBT-I for Sleep, Pain, and Inflammation in Crohn's Disease

NCT05034159
COMPLETED NA

The Effect of Touch on Pain and Anxiety During the Bone Marrow Biopsy Procedure

NCT04935775
TERMINATED NA

Trusted Messenger Intervention

NCT05167422
COMPLETED

ICG 24h Prior to Operative Treatment of Orthopaedic Infection

NCT04927637
COMPLETED NA

A Single Arm Pilot Study to Refine a Novel Approach to Exercise Promotion Based on Affect-regulation

NCT04903249
TERMINATED NA

EFFECTIVENESS: Hopewell Hospitalist: A Video Game Intervention to Increase Advance Care Planning by Hospitalists

NCT04881968
COMPLETED NA

ED Tracking Sheet Implementation

NCT05213923
COMPLETED NA

Determining Feasibility and Acceptability of Sharing Video Recordings With Patients With ALS and Caregivers

NCT04719403
COMPLETED NA

A Pilot Randomized Trial of Video-based Family Therapy for Depressed Home Visited Mothers

NCT04741776
COMPLETED NA

Improving Patient and Caregiver Engagement by Sharing Annotated Audio-recorded Clinic Visits

NCT04827381
COMPLETED

Detection and Delineation of Necrotizing Fasciitis Via a Vascular Perfusion Fluorophore

NCT04839302
COMPLETED NA

Patient Reported Outcomes and Patient Education in Cellular Therapy Patients

NCT04853277
COMPLETED NA

Peer-delivered and Technology-Assisted Integrated Illness Management and Recovery

NCT04481737
TERMINATED

A 48 Subject Study Using Non-invasive Multi-Technology Measurements for Early Detection of Ongoing Hemorrhage

NCT04814810
COMPLETED NA

CORE: CO Monitoring for Reach and Efficacy in Tobacco Treatment for Cancer Patients

NCT04675515
COMPLETED NA

Sous Vide Rewarming for Frostbitten Extremities

NCT04633174
COMPLETED NA

Feasibility of a Goal-based Agenda Setting Intervention

NCT04696484
COMPLETED Phase 1

Task-Based Grounding Program

NCT04648553
COMPLETED NA

Wraparound for High-risk Families with Substance Use Disorders: Examining Family, Child, and Parent Outcomes

NCT04637581
COMPLETED NA

HOBSCOTCH Phase III

NCT04519775
COMPLETED NA

Education About Health and Cancer Study

NCT04409782
COMPLETED NA

EHR Embedded Comparative Effectiveness Studies--WWC

NCT04514679
COMPLETED NA

EHR Embedded Comparative Effectiveness Studies--CPS

NCT04520009
COMPLETED NA

Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy

NCT04526886
COMPLETED NA

Behavioral Activation in Orthopaedic Trauma Patients: A Pilot Study

NCT04426981
COMPLETED NA

Screen to Save 2: Rural Cancer Screening Educational Intervention

NCT04414306
COMPLETED NA

A Mind-Body Intervention for Diabetes Management: A Pilot Study

NCT04944264
COMPLETED NA

Brief COVID-19 Intervention for People With Serious Mental Illness and Co-Morbid Medical Conditions

NCT05467982
COMPLETED Early Phase 1

Intraoperative Ketamine for Patients Undergoing Total Joint Arthroplasty

NCT04437888
COMPLETED

ICG Fluorescence Imaging in Post-traumatic Infection

NCT04403204
COMPLETED

Transthoracic Echocardiography of Ventricular Function of Parturients in Labor

NCT04481503
COMPLETED NA

The Impact of Sharing Audio Recorded Clinic Visits on Self-management in Older Adults

NCT04344301
COMPLETED

Harnessing Digital Health to Understand Clinical Trajectories of Opioid Use Disorder

NCT04535583
COMPLETED NA

EFFICACY: Hopewell Hospitalist: A Video Game Intervention to Increase Advance Care Planning by Hospitalists

NCT04557930
COMPLETED

Artificial Intelligence for Prostate Cancer Treatment Planning

NCT04441775
COMPLETED NA

Point-of-care Anorectal Testing to Predict Outcomes With Biofeedback Therapy: Clinical Trial

NCT04159350
COMPLETED

Developing an Experimental Framework to Evaluate Oncologist Emotion Regulation

NCT05365763
COMPLETED NA

Dartmouth Middle Meningeal Embolization Trial (DaMMET)

NCT04270955
COMPLETED

Lumpectomy Specimen Margin Evaluation With Tomography and Structured Light Imaging

NCT04257799
COMPLETED

ICG Fluorescence Imaging in Lower Extremity Amputation Patients

NCT04250558
COMPLETED NA

Comparative Effectiveness of Direct Admission & Admission Through Emergency Departments for Children

NCT04192799
← Previous Page 3 of 9 Next →

Phase Distribution

PhaseTrial count
Phase 1 44
Phase 2 40
Phase 3 6
Phase 4 19

Therapeutic Areas

Breast Cancer 12
Schizophrenia 7
Depression 6
Substance-Related Disorders 5
Schizoaffective Disorder 5
Cognitive Dysfunction 5
Bipolar Disorder 5
Trauma Injury 4
Colorectal Cancer 4
Memory Impairment 3

What is open in the Dartmouth-Hitchcock Medical Center pipeline

52 recruiting of 427 indexed (12% open); 300 completed (70%).

Phase mix: 25 late (III/IV) vs 84 early (I/II) (early-phase heavy).

Top condition: Breast Cancer (12 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Dartmouth-Hitchcock Medical Center: open-pipeline peers nationwide

Peers matched on 427 registered trials and 12% open enrollment, not the therapeutic-area sidebar.

Dartmouth-Hitchcock Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400500 0%10%20%30% Total trials Recruiting share Dartmouth-Hitchcock Medical CenterUniversity of Illinois at ChicagoVanderbilt UniversityChildren's Hospital of PhiladelphiaNovo Nordisk A/SFriends Research InstituteAntonios LikourezosOregon State UniversityUniversity of Massachusetts, Amherst
Dartmouth-Hitchcock Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Dartmouth-Hitchcock Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 427 trials (± recruiting share)

Sponsors near 12% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Dartmouth-Hitchcock Medical Center page

427 registered trials is a research-attention snapshot, not an endorsement of Dartmouth-Hitchcock Medical Center or any single study.

  • 52 of Dartmouth-Hitchcock Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Breast Cancer is the condition Dartmouth-Hitchcock Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Dartmouth-Hitchcock Medical Center pipeline card: 427 registered trials from official public datasets.Report a data error.